Treatment Outcome

"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.

Descriptor ID	D016896
MeSH Number(s)	E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
Concept/Terms	Treatment Outcome Treatment Outcome Outcome, Treatment Clinical Effectiveness Clinical Effectiveness Clinical Effectivenesses Effectiveness, Clinical Effectivenesses, Clinical Patient-Relevant Outcome Outcome, Patient-Relevant Outcomes, Patient-Relevant Patient Relevant Outcome Patient-Relevant Outcomes Clinical Efficacy Efficacy, Clinical Treatment Effectiveness Treatment Effectiveness Effectiveness, Treatment Treatment Efficacy Efficacy, Treatment Rehabilitation Outcome Rehabilitation Outcome Outcome, Rehabilitation

Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]
Treatment Outcome [E01.789.800]
Health Care [N]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment (Health Care) [N04.761.559]
Outcome Assessment (Health Care) [N04.761.559.590]
Treatment Outcome [N04.761.559.590.800]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Outcome and Process Assessment (Health Care) [N05.715.360.575]
Outcome Assessment (Health Care) [N05.715.360.575.575]
Treatment Outcome [N05.715.360.575.575.800]

Below are MeSH descriptors whose meaning is related to "Treatment Outcome".

Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".

Treatment Outcome
Response Evaluation Criteria in Solid Tumors
Sustained Virologic Response
Therapeutic Index
Treatment Failure

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.

Bar chart showing 4136 publications over 31 distinct years, with a maximum of 259 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	8	8
1996	0	14	14
1997	0	12	12
1998	0	18	18
1999	2	27	29
2000	0	21	21
2001	1	20	21
2002	1	61	62
2003	4	71	75
2004	1	89	90
2005	0	98	98
2006	1	103	104
2007	3	119	122
2008	0	150	150
2009	0	142	142
2010	0	186	186
2011	0	170	170
2012	0	203	203
2013	1	208	209
2014	2	248	250
2015	3	218	221
2016	3	222	225
2017	2	252	254
2018	4	213	217
2019	2	225	227
2020	1	258	259
2021	2	166	168
2022	1	172	173
2023	0	168	168
2024	0	185	185
2025	0	55	55

Below are the most recent publications written about "Treatment Outcome" by people in Profiles.

Reddy VY, Gerstenfeld EP, Schmidt B, Nair D, Natale A, Saliba W, Verma A, Sommer P, Metzner A, Turagam M, Weiner S, Champagne J, Garcio-Bolao I, Calkins H, Olson J, Issa Z, Winner M, Su W, Tomassoni G, Kim J, Hook B, Delurgio DB, Gibson DN, Daccarett M, Patel C, Bhalla K, Shehata M, Harding JD, Cheung JW, Raybuck JD, Roelke S, Schwartz T, Sutton BS, Mansour M. Pulsed Field Ablation for Persistent?Atrial?Fibrillation: 1-Year Results of ADVANTAGE AF. J Am Coll Cardiol. 2025 May 06; 85(17):1664-1678.

View in: PubMed
Tambiah J, Kennedy S, Swearingen C, McAlindon T, Yazici Y. Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. Rheumatology (Oxford). 2025 May 01; 64(5):2583-2590.

View in: PubMed
Butterfield NN, Luzon Rosenblut C, Fava M, Correll CU, Rothschild AJ, Murrough JW, Mathew SJ, Beatch GN, Grayson C, Harden C, Qian J, McIntosh J, Namdari R, Kenney C. Azetukalner, a Novel KV7 Potassium Channel Opener, in Adults With Major Depressive Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2025 May 01; 8(5):e2514278.

View in: PubMed
Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. N Engl J Med. 2025 May 01; 392(17):1710-1720.

View in: PubMed
Oliveto AH, McGaugh J, Chopra MP, Thostenson J, Mancino MJ. A randomized clinical trial of disulfiram at higher doses for the treatment of cocaine use disorder among methadone-stabilized patients. J Psychiatr Res. 2025 Jun; 186:387-395.

View in: PubMed
Dora D, Revisnyei P, Pasic A, Galffy G, Dulka E, Mihucz A, Rosk? B, Szincsak S, Iliuk A, Weiss GJ, Lohinai Z. Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients. Front Immunol. 2025; 16:1543817.

View in: PubMed
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H. Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis. N Engl J Med. 2025 May 15; 392(19):1893-1904.

View in: PubMed
Carter E, Banerjee S, Alexopoulos GS, Bingham KS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ. Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach. J Affect Disord. 2025 Jul 15; 381:291-297.

View in: PubMed
Tan CR, Asoori S, Huang CY, Brunaldi L, Popat R, Kastritis E, Martinez-Lopez J, Bansal R, Silva Corraes AM, Chhabra S, Parrondo R, Ailawadhi S, Fotiou D, Dimopoulos MA, Yong K, Mactier C, Lau C, Corona M, Marin AJS, Mian H, Durie BG, Usmani SZ, Martin TG, Lin Y. Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study. Blood Cancer J. 2025 Apr 03; 15(1):53.

View in: PubMed
McClennen T, Carvalho B, Yousef M, Ayers DC. Evaluating Robotic-Assisted Total Knee Arthroplasty Compared to Conventional Methods: A Systematic Review of the Literature in the United States. Int J Med Robot. 2025 Apr; 21(2):e70067.

View in: PubMed

People

Explore

Similar Concepts

Top Journals